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The influenza virus genome is transcribed in the nuclei of infected cells but assembled into progeny virions
in the cytoplasm. This is reflected in the cellular distribution of the virus nucleoprotein (NP), a protein which
encapsidates genomic RNA to form ribonucleoprotein structures. At early times postinfection NP is found in
the nucleus, but at later times it is found predominantly in the cytoplasm. NP contains several sequences
proposed to act as nuclear localization signals (NLSs), and it is not clear how these are overridden to allow
cytoplasmic accumulation of the protein. We find that NP binds tightly to filamentous actin in vitro and have
identified a cluster of residues in NP essential for the interaction. Complexes containing RNA, NP, and actin
could be formed, suggesting that viral ribonucleoproteins also bind actin. In cells, exogenously expressed NP
when expressed at a high level partitioned to the cytoplasm, where it associated with F-actin stress fibers. In
contrast, mutants unable to bind F-actin efficiently were imported into the nucleus even under conditions of
high-level expression. Similarly, nuclear import of NLS-deficient NP molecules was restored by concomitant
disruption of F-actin binding. We propose that the interaction of NP with F-actin causes the cytoplasmic
retention of influenza virus ribonucleoproteins.
The influenza A virus genome consists of eight segments of
negative-sense single-stranded RNA (vRNA) which are tran-
scribed in infected cells to yield two types of positive-sense
transcripts: capped and polyadenylated mRNAs and exact
complements (cRNA) which serve as replicative intermediate
RNAs for the production of further vRNAs (18). Four viral
proteins are necessary and sufficient to carry out this process
(16): the three subunits of an RNA-dependent RNA polymer-
ase (PB1, PB2, and PA) and a 55-kDa single-stranded RNA-
binding nucleoprotein (NP). Indeed, the v- and cRNA seg-
ments are always associated with these polypeptides to form
ribonucleoprotein (RNP) structures, thought to comprise one
copy of the trimeric polymerase and approximately one NP
polypeptide per 20 bases of RNA (18).
Unusually for a virus with no DNA coding stage, influenza
virus transcription occurs in the nuclei of infected cells (15).
Thus, on initiation of infection the incoming RNPs are tar-
geted to the nucleus, and during infection newly synthesized
RNP proteins also undergo nuclear import. Consistent with
this, nuclear localization signals (NLSs) have been identified in
all four transcriptase proteins (9, 25, 26–28, 41, 41a), including
three in NP, the major protein component of RNPs. At early
times postinfection, the polymerase subunits and NP accumu-
late in the nucleus (reviewed in reference 18), and NP has been
shown to be necessary for the nuclear import of vRNA in
permeabilized cells (30). However, virion assembly, including
packaging of progeny RNPs, occurs in the cytoplasm and at
later times this is reflected in the cytoplasmic accumulation of
the four transcriptase proteins, generally assumed to be in the
form of RNPs (18). This differential localization of RNPs ne-
cessitates regulatory mechanisms, and evidence points to the
involvement of at least three viral polypeptides: the virion
matrix (M1) protein, the minor virion component NS2, and NP
itself. M1 is capable of binding to membranes, RNA, NS2, and
RNPs. In the virion, it is thought to act as the link between the
lipid envelope and the packaged genome segments (44). More-
over, M1 itself can localize to the nucleus, where it is thought
to promote the export of RNPs (22, 43). NS2, which binds to
RNPs via the M1 protein (47), has recently been shown to
possess a nuclear export signal (31). Microinjected anti-NS2
antibodies inhibit export of RNPs, and it has therefore been
proposed that NS2 is the viral factor directly responsible for
the export of RNPs from the nucleus (31). Accordingly, import
of NP (and RNPs early in infection) can be postulated to occur
because of the presence of NLSs and export can be postulated
to occur because of the subsequent expression of components
(M1 and NS2) that target RNPs to an export pathway (31, 44).
However, this hypothesis does not fully explain why RNPs
accumulate in the cytoplasm in the absence of M1 export (33,
42) or why a mutant influenza virus which synthesizes very little
or no NS2 is fully replication competent (36, 45). Moreover,
since vRNA synthesis is not temporally separated from RNP
export, it is not clear how import of newly synthesized NP is
maintained in the presence of active export of the same
polypeptide in the form of RNP complexes, or why cytoplasmic
RNPs are not simply reimported back into the nucleus by
virtue of their polyvalent NLS sequences. Therefore, there must
be other elements involved in the control of RNP localization.
NP possesses the ability to locate to both cytoplasm and
nucleus. In the absence of other viral proteins, it shuttles be-
tween the two compartments (43), which suggests that it inter-
acts with the cellular nuclear export apparatus in the absence
of M1 and NS2. NP can also accumulate in the cytoplasm at
“late” times postexpression (27), indicating that the activities
of the NP NLSs are modulatable. Therefore, RNP localization
may also be regulated by mechanisms acting through NP. One
well-documented way of modulating nuclear import is through
interactions with cytoplasmic anchoring proteins (29, 40), and
recent work involving cell fractionation and fluorescent stain-
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ing experiments has suggested that cytoplasmic NP is associ-
ated with the cytoskeleton (3, 17).
Here we demonstrate that purified NP shows high-affinity
binding to filamentous actin (F-actin) in vitro with a Kd on the
order of 1 mM and a stoichiometry of 1 per actin subunit.
Additionally, there is a further interaction of lower affinity
which may reflect oligomerization of NP itself. We also show
the formation of complexes containing NP, RNA, and actin
and have identified a cluster of amino acid residues in NP
important for the interaction with F-actin. Localization of ex-
ogenously expressed NP was found to depend on the amount
expressed, with small amounts entering the nucleus and large
amounts accumulating in the cytoplasm, where the protein
colocalizes with F-actin. Mutations in NP which decrease F-
actin binding change the cellular distribution of the protein,
favoring accumulation in the nuclei even when the expression
level is high. We propose that F-actin binding acts as a cyto-
plasmic retention signal for NP.
MATERIALS AND METHODS
Plasmids, antisera, and viruses. A cDNA copy of A/PR8/34 segment 5 was
excised from plasmid pVB51 (6) with EcoRI and ligated into similarly linearized
plasmid pMAL-c2 (New England Biolabs). The NP and maltose binding protein
(MBP) open reading frames (ORFs) were then fused by oligonucleotide-directed
mutagenesis. The resulting plasmid (pMAL-NP) contains the lac promoter, the
MBP gene, a factor Xa protease recognition site, an alanine codon, and the NP
ORF (with an NcoI restriction enzyme site flanking the initiation codon). Point
mutations were introduced into this plasmid by standard procedures. All muta-
tions were confirmed by nucleotide sequencing of the appropriate region of the
NP gene. To construct a glutathione S-transferase (GST)–NP fusion protein,
plasmid pMAL-NP was digested with NcoI, end filled with the Klenow fragment
of DNA polymerase, and digested with EcoRI. The DNA fragment containing
the NP ORF was then ligated into SmaI-EcoRI-cut plasmid pGEX-2T (Phar-
macia) to create plasmid pGEX-NP. To obtain eukaryotic expression of non-
fused NP, NP genes were excised from the pMAL constructs by digestion with
NcoI and XbaI and inserted into similarly digested plasmid pKT0 (39). The
resulting plasmids (pKT5 series) contain the NP gene under control of a T7 RNA
polymerase promoter.
Antisera against NP were raised by immunizing rabbits with a b-galactosidase
fusion protein containing amino acids 340 to 498 of A/PR8/34 NP. Rabbit
antiserum to RNP cores was the generous gift of S. Inglis.
Recombinant vaccinia viruses expressing the three influenza virus A/PR8/34 P
proteins and NP (37) or bacteriophage T7 RNA polymerase (vTF-7 [11]) have
previously been described.
Expression and purification of NP. Exponentially growing cultures of Esche-
richia coli TG1 containing plasmid pMAL-NP, pGEX-NP, or pGEX-2T were
induced by the addition of isopropyl-thiol-b-galactosidase and incubated with
shaking for a further 4 h. Bacteria were pelleted by centrifugation and resus-
pended in a 1/5 culture volume of amylose column buffer (ACB) (500 mM NaCl,
20 mM Tris-Cl [pH 7.6], 1 mM EDTA, 0.02% sodium azide) (pMAL) or phos-
phate-buffered saline (PBS) (pGEX), containing 0.25 mg of lysozyme per ml.
After incubation for 30 min on ice and overnight at 220°C, the suspension was
thawed and sonicated before centrifugation at an average of 9,000 3 g for 30 min.
The supernatants were sequentially filtered through Whatman no. 1 filter paper
and a 0.45-mm-pore-size cellulose acetate filter before chromatography over
amylose resin (New England Biolabs) or glutathione Sepharose (Pharmacia) as
appropriate. Columns were washed sequentially with 10 volumes of ACB or PBS,
10 volumes of buffer containing 2 M NaCl, and another 10 volumes of ACB or
PBS. Bound protein was eluted with buffer supplemented with 10 mM maltose or
50 mM reduced glutathione.
The MBP moiety of MBP-NP was removed by the addition of 2 mM CaCl2 and
0.5% (wt/wt) factor Xa protease (New England Biolabs) in an overnight incu-
bation at 14°C. All polypeptides displayed the expected mobilities on sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (see Fig. 1)
and reacted as predicted in Western blots using anti-MBP, -GST, and -NP sera
(data not shown). Protein microsequencing confirmed the predicted N-terminal
sequence for NP cleaved from MBP. Proteins were either dialyzed or gel filtered
into 50 mM NaCl–10 mM HEPES (pH 8)–0.1 mM EDTA–10% glycerol (storage
buffer) and kept at 4 or 270°C. Protein concentrations were determined by the
Bradford method (7) or by absorbance at 280 nm with a molar extinction
coefficient of 119,000 M21 z cm21 calculated according to the formula of Gill and
von Hippel (13). All samples were clarified by centrifugation at an average of
390,000 3 g for 15 min before use.
Actin-binding assays. Purified rabbit muscle actin (38) was polymerized in 100
mM NaCl–10 mM Tris-Cl (pH 8.0)–1 mM MgCl2–0.1 mM ATP–0.2 mM
EGTA–1 mM sodium azide (F buffer). Sedimentation assay mixtures contained
3 mM actin in 50 mM NaCl–10 mM HEPES (pH 7.6)–1 mM MgCl2–10%
glycerol–0.1 mM EDTA–0.1 mM ATP in a final volume of 100 ml. After being
mixed, the samples were centrifuged at an average of 200,000 3 g for 20 min at
20°C before separation into pellet and supernatant fractions. Equivalent
amounts of the two fractions were analyzed by SDS-PAGE and stained with
Coomassie brilliant blue dye. Quantitation was performed by using a Molecular
Dynamics computing densitometer (32). For electron microscopy, actin (1 mM)
and MBP or MBP-NP were mixed in F buffer and left on ice for 20 min. Drops
(30 ml) were applied to carbon-coated grids for 1 min and then grids were rinsed
with 5 drops of F buffer and 5 drops of 1% uranyl acetate before being blotted
dry and viewed in a Philips 208S electron microscope at a magnification of 20,000
or 30,000.
RNA transcription and binding assays. For in vitro RNA binding assays, a
radiolabelled 178-nucleotide synthetic RNA target was generated by in vitro
transcription of plasmid pKT8-D3959 (generous gift of K. Tibbles) with bacterio-
phage T7 RNA polymerase in the presence of a-[32P]CTP (100 mM; specific
activity, 2 Ci/mmol) according to standard procedures. The transcript corre-
sponds to influenza virus A/PR8/34 segment 8 but with nucleotides 84 to 795
(inclusive) deleted and a C-to-A transversion of the penultimate base. Shorter
transcripts corresponding to the minimal terminal repeat (“panhandle”) se-
quences or only the 39 end of segment 8 were generated by in vitro transcription
of the appropriate oligonucleotide templates cloned into plasmid pNEB193
(New England Biolabs). For in vivo RNA transcription assays, a synthetic influ-
enza virus genome segment containing an antisense chloramphenicol acetyltrans-
ferase (CAT) gene was produced by in vitro transcription of plasmid pPB2CAT
(generous gift of Mark Krystal). Filter binding assays were performed by incu-
bating protein samples with 20 fmol of RNA (around 5,000 cpm) in 25 mM
Tris-Cl (pH 7.6)–50 mM NaCl–5 mM MgCl2–0.5 mM dithiothreitol–5% glycerol
at room temperature for 20 min. The reaction mixtures were passed through
nitrocellulose filters equilibrated in 20 mM Tris-Cl (pH 7.6)–50 mM NaCl and
washed three times with 200 ml of the same buffer. Bound radioactivity was
quantified by liquid scintillation counting.
Transfection of tissue culture cells, transient replication assays, and indirect
immunofluorescence. BHK cells (in 35-mm-diameter dishes) were infected with
recombinant vaccinia viruses at a multiplicity of infection of 5 of each virus per
cell for 2 h at 37°C. The cells were washed three times with serum-free medium
before transfection with 1 mg of plasmid DNA encoding NP and 0.5 mg of
pPB2CAT9 in vitro-transcribed RNA and 10 mg of a cationic liposome mixture
(Lipofectin [GIBCO-BRL] or Escort [Sigma-Aldrich]), according to the manu-
facturers’ instructions. The cells were incubated at 37°C for 20 h, washed three
times with ice-cold PBS, and solubilized in 1 ml of CAT ELISA lysis buffer
(Boehringer Mannheim). The lysate was clarified by centrifugation at 14,000 3
g for 10 min at 4°C, and CAT expression was quantified relative to known
standards by a commercial enzyme-linked immunosorbent assay (Boehringer
Mannheim). Replication activities of mutants were calculated as percentages of
the CAT synthesis seen with the wild-type (WT) gene after subtraction of the
background obtained in the absence of NP. Values were calculated from a
minimum of three separate experiments and two independent plasmid DNA
preparations.
For immunofluorescence analysis, BHK or HeLa cells on coverslips were
infected and transfected with plasmid DNA as described above. After 4 h of
incubation at 37°C, the cells were washed three times with PBS containing 1%
newborn calf serum and fixed in PBS containing 4% formaldehyde for 20 min at
room temperature before being washed as before. The cells were permeabilized
with 0.2% TX-100 in PBS for 5 min at room temperature, washed, and incubated
for 1 h at room temperature with 200 ml of a 1-in-250 dilution of anti-RNP
serum. After cells had been washed, bound immunoglobulin G was stained with
swine anti-rabbit immunoglobulin G–fluorescein isothiocyanate conjugate
(DAKO). Coverslips were applied in the presence of an antiphotobleaching
compound (Citifluor). To preextract cells before fixation, cells were washed with
60 mM PIPES (pH 6.8)–20 mM HEPES–1 mM MgSO4–0.1 mM EGTA at 37°C,
incubated with the same buffer supplemented with 0.1% TX-100 and 5 mM
phallacidin for 2 min at room temperature, washed twice more, and then fixed
and processed as described above. F-actin was detected by using 5 nM
BODIPY-FL phallacidin (Molecular Probes), and b-actin was detected by using
monoclonal antibody clone AC-74 (Sigma) at a dilution of 1:50. Fluorescence
was viewed with a Leitz Orthoplan microscope or an MRC 1024 confocal mi-
croscope. Control experiments in which cells including untransfected cells were
stained with individual fluorescent reagents confirmed that the labelling was
channel specific (data not shown).
RESULTS
Binding of NP to F-actin. We tested whether purified NP
bound F-actin in vitro by a cosedimentation assay, in which
F-actin readily separates from monomeric protein by centrif-
ugation. As shown in Fig. 1, most of the actin sedimented after
centrifugation (lane 2) and only the expected critical actin
monomer concentration (0.1 to 0.2 mM) remained in the su-
pernatant (lane 1). Control assays showed that only trace
amounts of the expressed proteins pelleted in the absence of
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actin (Fig. 1, lanes 4, 8, and 12). However, when GST, GST-
NP, or MBP-NP was sedimented after mixing with F-actin, the
NP-containing polypeptides partitioned approximately evenly
between the supernatant and pellet fractions (Fig. 1, lanes 9,
10, 13, 14) while GST did not (lanes 5 and 6), demonstrating
association of NP with actin filaments. To test the ability of
nonfused NP to bind F-actin, MBP-NP was cleaved into MBP
and NP moieties by digestion with factor Xa protease and
sedimented with or without F-actin. Since MBP and actin
comigrate on SDS-PAGE, the samples were analyzed in par-
allel by Western blotting with an anti-MBP serum, confirming
that MBP alone did not pellet whether or not actin was present
(Fig. 1, inset, lanes 15 to 18). However, the NP polypeptide
pelleted only in the presence of actin (Fig. 1, lanes 15 to 18).
Thus, NP binds F-actin in vitro.
To quantitate the interaction between NP and F-actin, we
titrated increasing concentrations of MBP-NP with a constant
amount of F-actin in the sedimentation assay and determined
the amount bound. Figure 2 shows the molar ratio of MBP-NP
bound to F-actin as a function of the free MBP-NP. Saturation
occurred in excess of two NP molecules per actin subunit,
indicating more than one binding site for NP in the complex.
The curve could best be described (based on nonlinear least-
squares fitting) as resulting from a single high-affinity site per
actin subunit (approximate Kd, 1 mM) and a lower-affinity
site(s) having a Kd in excess of 40 mM. While we cannot
exclude the possibility that a second NP binding site is present
on F-actin, this weaker binding phase may be due to self-
association with already bound NP.
The binding of NP to actin filaments was also visualized
directly by electron microscopy. Actin filaments incubated with
an equimolar amount of MBP formed an essentially random
distribution of fibers (Fig. 3A). However, the addition of
MBP-NP to actin in an equimolar ratio induced a predomi-
nantly pairwise association of filaments (Fig. 3B), with a reg-
ular alternation of electron-dense and transparent regions be-
tween the filaments suggestive of cross-bridges (Fig. 3D).
Addition of higher ratios of NP to actin induced the bundling
of fibers into arrays containing multiple strands (Fig. 3C). The
spacing between the cross-bridge arrangements at equimolar
ratios of NP/actin was measured to be 332 6 39.5 Å, coincident
with every half-twist of the actin filament giving a ratio of 1
cross-bridge to every 13 actins. The formation of ordered bun-
dles of fibers confirms that NP binds F-actin and is also con-
sistent with the formation of NP-NP contacts.
RNA and the NP-actin interaction. Since NP is a single-
stranded-RNA-binding protein, we investigated the relation-
ship between actin binding and RNA binding. First, we exam-
ined the effect of actin on the ability of NP to bind RNA in
solution by titrating a radiolabelled 178-nucleotide RNA cor-
responding to the 59 and 39 noncoding sequences from vRNA
segment 8 with increasing concentrations of MBP, MBP-NP,
and MBP-NP plus 3 mM actin. Addition of MBP up to a
concentration of 300 nM did not result in significant retention
of the labelled probe, indicating that MBP itself does not bind
RNA (Fig. 4a). However, titration with increasing amounts of
MBP-NP resulted in the retention of 50% of the input RNA
with around 20 nM protein (Fig. 4a). In replicate experiments,
the affinity of MBP-NP for RNA was determined to be 16.3 6
3.8 nM21 (n 5 5), which is in good agreement with that
FIG. 1. F-actin-binding activities of GST, GST-NP, and MBP-NP. The proteins (MBP/NP corresponds to MBP-NP digested with factor Xa protease) were
centrifuged in the presence (1) or absence (2) of 3 mM F-actin. Supernatant (S) and pellet (P) fractions were analyzed by SDS-PAGE and staining with Coomassie
blue or by Western blotting with anti-MBP serum (inset, lanes 15 to 18). Arrows indicate the named polypeptides (right), and molecular mass markers (in kilodaltons)
are indicated on the left.
FIG. 2. Titration binding curves of WT and R156-A MBP-NP for F-actin.
Sedimentation assays were performed by using 3 mM F-actin and WT (open
circles) or mutant R156-A (closed circles) MBP-NP. The amount of bound
MBP-NP (expressed as the molar ratio relative to actin) is plotted against the
concentration of free MBP-NP.
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estimated for NP purified from influenza virus virions (20
nM21 [4]). Therefore, the bacterially expressed NP behaved
similarly to native NP and was fully competent to bind RNA.
Moreover, addition of F-actin to the reaction mixtures had no
significant effect on this RNA-binding activity (Fig. 4a).
Since NP binds to RNA with higher affinity than it does to
actin (Kd ;16 nM versus 1 mM [Fig. 2 and 3]), we examined the
effect of a molar excess of RNA on actin binding by NP. We
used a 34-mer transcript corresponding to the 39 end of seg-
ment 8, which is long enough to bind efficiently to NP (47) but
is not sufficiently large to bind multiple copies of NP and thus
form RNP structures which would sediment irrespective of any
association with actin fibers. In control reactions, this RNA did
not cause a significant increase in the quantity of MBP-NP that
pelleted in the absence of actin (Fig. 4b, lanes 5 to 8). How-
ever, the extent of sedimentation of MBP-NP with F-actin was
unaffected by the presence of a twofold molar excess of RNA
transcript relative to NP (Fig. 4b, compare lanes 1 and 2 with
lanes 3 and 4).
To test whether NP was capable of binding both actin and
RNA simultaneously, we assayed the sedimentation of radio-
labelled RNAs (either the 39 end [34-mer] or the 59 and 39
panhandle sequences [56-mer] of segment 8) with actin and
MBP-NP. Mixtures of RNA, actin, and MBP-NP were sub-
jected to centrifugation, and the pellet fractions were exam-
ined for their RNA content. Figure 4c shows that substantial
quantities of both radiolabelled RNAs associated with the
MBP-NP and the actin pellet (Fig. 4c). By contrast, there was
no binding to actin alone (Fig. 4a) and minimal binding to
MBP-NP alone (Fig. 4c), presumably reflecting the presence of
oligomerized MBP-NP. Thus, NP, RNA, and F-actin can exist
in termolecular complexes.
Mutational analysis of actin binding. To further delineate
the NP–F-actin interaction, we performed a mutational anal-
ysis of NP. On the grounds that an interaction with a relatively
invariant protein such as actin might be reflected by sequence
conservation within NP, we altered residues in regions con-
served among the NPs of influenza A, B, C, and Dhori viruses
(12) (summarized in Fig. 5b) and tested the effects of the
mutations on actin-binding activity. Many of the mutations had
no effect on the interaction. Quantitative analysis of the
R156-A mutant produced a binding curve indistinguishable
from that of the WT polypeptide (Fig. 2). Similarly, when
tested at concentrations in the low micromolar range, the
W104-F and R391-A mutants bound efficiently to F-actin (Fig.
5a, panels ii and vi, respectively; cf. panel i [WT]). The binding
affinities for F-actin of these and the R8-A, W120-A, R199-A,
K236-A, and R267-A mutants were found to vary from that of
the WT protein by less than threefold (Fig. 5b). However, the
F338-A, E339/D340-AA, R342-A, and Q405-A polypeptides
showed markedly different behavior, with the majority of each
protein remaining in the supernatant fractions at each concen-
tration tested (Fig. 5a, panels iii, iv, v, and vii). Quantification
produced estimated binding constants for F-actin some 10- to
35-fold lower than for the WT protein (Fig. 5b). Thus, four
mutations that disrupted the ability of the protein to bind
F-actin were identified in the C-terminal one-third of NP.
Ability of actin-binding mutants to support viral transcrip-
tion. Although we had identified mutations that reduced the
ability of NP to bind actin, it was necessary to examine whether
FIG. 3. Electron microscopy of actin filaments mixed with equimolar concentrations of MBP (A) and MBP-NP (B and D) and a threefold excess of MBP-NP (C).
Scale bars, 300 nm.
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the mutations affected other functional properties of NP. Many
lines of evidence indicate that NP is essential for virus RNA
synthesis (18). This has been confirmed in a recombinant sys-
tem where NP and the three subunits of the influenza virus
RNA polymerase are necessary and sufficient to drive tran-
scription and replication of a synthetic influenza virus genome
segment containing an antisense CAT (flu-CAT) reporter gene
(16). We used an adaptation of this assay to apply the stringent
FIG. 4. RNA and the interaction between NP and F-actin. (a) Effect of actin on the RNA-binding activity of NP. The amounts of radiolabelled RNA (1 nM) bound
by MBP (circles), MBP-NP (squares), and MBP-NP plus 3 mM F-actin (triangles) were determined by a filter assay. (b) Effect of RNA on actin binding by NP. MBP-NP
(0.75 mM) was cosedimented in the presence (1) or absence (2) of 3 mM F-actin with the indicated molar ratio of a 34-mer RNA. S, supernatant; P, pellet. (c)
Cosedimentation of RNA with actin and NP. Radiolabelled 34-mer (100 nM in 100 ml; open bars) or 54-mer (50 nM; shaded bars) was cosedimented in the presence
of 3 mM MBP-NP with or without 3 mM F-actin.
FIG. 5. Identification of NP point mutations which disrupt actin binding. (a) WT or mutant MBP-NP polypeptides were cosedimented in the absence (2) or
presence (1) of 3 mM F-actin, and supernatant (S) and pellet (P) fractions were examined by SDS-PAGE. (b) Summary of point mutations and cellular localization
signals in NP. Arrows indicate the positions of amino acid changes introduced into NP. White arrows indicate mutations with no major effect on F-actin binding and
black arrows indicate those that substantially reduced binding. Tabulated values are the fold decrease in binding affinity for F-actin relative to values for the WT protein.
Also shown are the positions of the three postulated cellular localization signals that have been identified in NP.
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test of whether the mutants defective in actin binding could
support virus RNA synthesis.
The WT and mutant NP genes were subcloned into plasmid
pKT0 (as described in Materials and Methods) to allow T7
RNA polymerase-driven expression of native NP. BHK cells
were multiply infected with vaccinia viruses expressing the
influenza virus RNA polymerase and bacteriophage T7 RNA
polymerase (11, 37) and transfected with flu-CAT RNA and
plasmids encoding WT or mutant NP, and the accumulated
CAT polypeptide levels were measured 20 h later. Control
experiments established that, as expected, the flu-CAT gene
was transcribed and replicated to produce CAT polypeptide in
the presence of the influenza virus RNA polymerase and NP
and that NP was essential for this process (data not shown).
The activities of the mutants were then quantified relative to
that of the WT gene. The E339/D340-AA mutant failed to
support the accumulation of CAT polypeptide (0.1% 6 0.3%).
However, the Q405-A mutant supported CAT synthesis to a
degree indistinguishable from that of the WT protein (98.2%
6 10.1%), while the F338-A and R342-A mutants possessed
somewhat diminished (61.0% 6 20.3% and 23.9% 6 6.5%,
respectively) activity. Hence, the last three mutants are capable
of successfully participating in the multiple protein-protein and
protein-RNA interactions necessary for the formation of a
transcriptionally active influenza virus RNP core.
Actin and the intracellular localization of NP. Since F-actin
is cytoplasmic and NP can also accumulate in the cytoplasm,
we examined the relevance of actin binding to the localization
of NP. Because exogenously expressed NP shuttles between
nucleus and cytoplasm and has been shown to accumulate in
the cytoplasm under certain circumstances (27, 43), we first
established the localization parameters of the WT polypeptide
in our expression system by testing the effect of expression
levels on the compartmentalization of NP. BHK cells were
infected with a recombinant vaccinia virus expressing T7 RNA
polymerase and transfected with various amounts of plasmid
pKT5, and the subsequent expression and cellular localization
of NP were examined by indirect immunofluorescence at 4 h
posttransfection. Nontransfected cells revealed only a diffuse,
low-level fluorescence (data not shown). In contrast, cells
transfected with a plasmid containing the WT NP gene exhib-
ited strong fluorescence, the location of which depended on
the amount of plasmid transfected. In cells transfected with a
high dose of plasmid (0.3 mg/105 cells), virtually all the fluo-
rescence was cytoplasmic, often with apparent sparing of the
nucleus (Fig. 6a). However, cells transfected with a low dose of
plasmid (3 ng/106 cells) showed almost exclusively nuclear flu-
orescence (Fig. 6c). Cells transfected with an intermediate
amount of plasmid (30 ng/105 cells) showed an intermediate
pattern, with many cells containing substantial amounts of
cytoplasmic NP but with nuclear accumulation as well (Fig.
6b). When lysates from cells transfected in parallel were sub-
jected to SDS-PAGE and Western blot analysis to assess the
quantity of NP expressed, the amount correlated with the plas-
mid dose (data not shown). The transfection efficiency varied
by less than twofold (generally ranging between 20 and 40%;
data not shown) over the range of plasmid concentrations
tested. This indicates that the expression levels depended pri-
marily on the amount of plasmid received per cell and not the
number of cells transfected. Thus, the cellular distribution of
NP depended on the amount (or rate) of synthesis of protein
within any one cell.
We next tested whether cytoplasmic NP associated with F-
actin in vivo. The perinuclear actin network in cells was visu-
alized by staining with anti-b-actin as an irregular ring struc-
ture that at most but not all points coincided with anti-NP
fluorescence (Fig. 7a to c). Striking colocalization of NP and
b-actin was also observed at the periphery of cells, particularly
at the leading edges of lamellipodia (Fig. 7d to f). We also saw
colocalization of NP with b-actin that had been incorporated
into stress fibers (data not shown). To examine this further, we
extracted cells with nonionic detergent before fixation, to re-
move soluble cytosolic proteins, and stained them with anti-NP
and fluorescent phallacidin, a reagent that preferentially binds
to actin in the form of stress fibers. Under these conditions,
substantial quantities of NP remained cell associated, but in a
granular pattern, often denser in the perinuclear area (data not
shown). Moreover, many of the granules were arranged in
linear arrays coincident with the phallacidin-stained F-actin
FIG. 6. Cellular localization of WT and mutant NP polypeptides. BHK cells
(105) were infected with a recombinant vaccinia virus expressing T7 RNA poly-
merase, transfected with the indicated amounts of plasmids, and examined 4 h
later by indirect immunofluorescence with anti-NP serum.
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stress fibers (Fig. 7g to i). In addition, colocalization between
NP and actin was observed in a variety of cell types, including
HeLa (Fig. 7a to f), BHK (Fig. 7g to i), and CV1 cells (data not
shown). Therefore, exogenously expressed NP interacts with
actin in vivo.
We next examined the intracellular localization of mutant
NP molecules defective for actin binding. Significantly, even
when cells were transfected with high doses of plasmids en-
coding these mutants, the fluorescence was predominantly nu-
clear (Fig. 6d and e). This increased nuclear accumulation was
not simply the result of lower expression of the mutants, since
the amounts of polypeptide detected by SDS-PAGE and West-
ern blot analysis of parallel transfections were comparable with
those of the WT polypeptide (relative densitometric scores of
1.1 6 0.1 and 1.0 6 0.2 for F338-A and Q405-A, respectively;
data not shown). This suggests that the F338-A and Q405
polypeptides are more karyophilic than the WT protein.
To examine further the effect of mutations affecting actin
binding on the cellular localization of NP, we tested the effects
of combining them with a mutation (R8-A [Fig. 5b]) that dis-
rupted the N-terminal mammalian NLS (41). In BHK cells, the
R8-A mutation rendered NP almost exclusively cytoplasmic at
4 h posttransfection regardless of the amount of plasmid trans-
fected (Fig. 8a and b). In contrast to the situation for WT NP,
FIG. 7. Colocalization of NP and F-actin. Cells were transfected with 0.3 mg of pKT5 and examined 4 h later by confocal laser microscopy after staining for NP
(red) or actin (green). Panels b, e, and h are images resulting from the merger of the red and green channels. Panels a through f are from HeLa cells fixed before
detergent extraction. Panels g through i are from a BHK cell extracted with detergent before fixation.
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even levels of R8-A expression that were barely detectable by
immunofluorescence resulted in cytoplasmic staining and ap-
parent sparing of the nucleus (Fig. 8b; cf Fig. 6c). This is
consistent with the importance of the N-terminal NLS for
nuclear import in mammalian cells (Fig. 5, NLS-1) (41). Com-
bining the R8-A mutation with others that did not affect actin
binding also resulted in a staining pattern where the nuclei
emitted lower-intensity fluorescence than did the cytoplasm
(Fig. 8c [R8-R391] and data not shown [R8-K236]). However,
when either of the F338-A, E339/D340-AA, or R342-A muta-
tions (which disrupt actin binding) were introduced into R8-A,
the ability of the polypeptide to accumulate in the nuclei of
cells was partially restored (Fig. 8d to f). Therefore, mutations
which weaken the affinity of NP for actin can compensate for
a mutation which disrupts a nuclear import signal. Thus, the
NP-actin interaction causes cytoplasmic retention of NP.
DISCUSSION
Two recent studies suggested that influenza virus NP inter-
acts with microfilaments of the host cell cytoskeleton late in
infection (3, 17). Both reports found that NP partitioned into
cytoskeleton-containing pools during biochemical fraction-
ation of infected cells; that NP colocalized with microfilaments,
especially at the cell periphery; and that disruption of micro-
filaments with cytochalasins altered the distribution of NP.
Here, we confirm and extend these observations by using two
methods to show that NP binds directly to F-actin in vitro (Fig.
1 to 3) with an affinity comparable to that of many cellular
F-actin-binding proteins (35). We also show that NP associates
with actin filaments in vivo in the absence of other influenza
virus proteins (Fig. 7). Furthermore, complexes containing F-
actin, NP, and RNA could be formed (Fig. 4). As the in vitro
actin-binding assay employed high-speed centrifugation, we
could not directly test whether authentic RNP particles bound
F-actin because they sediment under these conditions, but we
predict that RNP structures bind F-actin.
We have identified point mutations in NP which weaken its
affinity for actin in vitro (Fig. 5) and decrease the extent of
colocalization of the proteins in vivo (Fig. 6 and 8). These
mutations were largely localized to a region of NP previously
identified as important for the accumulation of the protein in
the nuclei of Xenopus oocytes (9). The signal mapped by Davey
and colleagues was one of the first NLSs proposed, but as
subsequent NLSs are identified, it appears increasingly atypi-
cal. In sequence composition, it does not possess the small
stretch of basic amino acids found in other viral proteins such
as simian virus 40 large T antigen, or the bipartite basic NLS
contained in many cellular proteins (10). In oocytes it acts as a
sequence which causes the retention of NP that has diffused
into the nucleus, rather than as a signal for the active uptake of
the protein; hence it was called a “nuclear accumulation” sig-
nal (NAS) (9). Subsequently, the study of Wang et al. (41)
found that this NAS was not essential for nuclear localization
of NP in mammalian cells. Here we show that mutation of
residues within the NAS actually increases the ability of NP to
localize to the nuclei of mammalian cells (Fig. 6 and 8). The
reason for the discrepancy between the activities of the NAS in
mammalian and amphibian cells is not clear, but the fact that,
unlike most somatic cells, the nuclei of amphibian oocytes have
been shown to contain actin may be relevant (8, 34). Never-
theless, the region of NP defined as the NAS, which we find
important for actin binding, is one of the most highly conserved
blocks of amino acids between influenza A, B, C, and Dhori
virus NPs (12), suggesting that it is functionally important.
The most plausible role for the NP-actin interaction is dur-
ing the late stages of viral infection, when NP is also found in
the cytoplasm. In this study, we show that the cellular local-
ization of exogenously expressed NP depends on the amount of
protein synthesized. Low levels of NP were targeted efficiently
to the nucleus, but in a dramatic switch, large amounts local-
ized almost exclusively to the cytoplasm (Fig. 6), where in part
NP associated with actin (Fig. 7). These phenomena could
perhaps be explained by saturation of the nuclear import ma-
chinery leading to cytoplasmic accumulation of NP and subse-
quent F-actin binding. However, the fact that all the mutations
that weakened F-actin binding restored nuclear import, even
under conditions of high-level expression (Fig. 6) or in the
absence of a functional N-terminal NLS (Fig. 8), strongly im-
plies a causative link between F-actin binding and cytoplasmic
retention of NP. We propose that the interaction between NP
and actin plays a role in regulating the localization of RNPs by
causing their cytoplasmic retention late in infection. Previous
work has shown that nuclear import of NP and RNPs is driven
by NLSs in NP and that export of RNPs depends at least in
part on the subsequent expression of M1 and NS2. Mechanis-
tically, retention of RNPs on cytosolic actin filaments would act
in opposition to the import pathway, but in concert with the
export pathway, to prevent reimport of exported RNPs des-
tined for packaging into progeny virions.
FIG. 8. Cellular location of NP mutants bearing amino acid substitutions in
NLS I. Cells transfected with 0.3 mg (except for those shown in panel b, which
were transfected with 3 ng) of plasmids encoding the indicated mutants were
examined by indirect immunofluorescence with anti-NP serum.
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Cytosolic anchoring as a means of regulating nuclear local-
ization is well established for several cellular proteins, such as
the transcription factors of the NF-kB family, or Xenopus xnf7
(29, 40). In the case of NF-kB, retention is thought to result
from masking of the NLS by the cytoplasmic anchor, since the
addition of an extra NLS overrides the retention mechanism
(5). In contrast, Xenopus xnf7 remains cytoplasmic even after
addition of another NLS, leading to the proposal that cytoplas-
mic retention results from a physical interaction with a fixed
anchor, possibly the cytoskeleton (20). Here we show that
direct interaction with actin microfilaments mediates cytoplas-
mic retention of an NLS-containing protein. This represents a
novel mechanism for controlling the cellular location of a ri-
bonucleoprotein complex and may be applicable to a wider
range of cellular proteins and RNAs.
It seems likely that the interaction between NP and actin is
subject to regulation. The quantity of actin in the cell is such
that the switch in NP localization between low- and high-dose
transfections cannot be explained purely in terms of the pro-
tein’s affinity for actin. In addition, the nonuniform colocaliza-
tion of NP with actin (Fig. 7) also suggests a regulated process.
Since the microfilament network in cells consists of a polarized
distribution of the various actin isoforms in complex with many
different cellular actin-binding proteins (14), this could reflect
a largely passive process, resulting from the occlusion of po-
tential actin-binding sites and/or preferential binding to others.
However, influenza virus may also have evolved positive mech-
anisms for regulating the NP-actin interaction, a likely candi-
date being phosphorylation of NP (2, 27). This is consistent
with the effect of protein kinase inhibitors on NP localization
noted by Neumann et al. (27), while phosphorylation is a well-
documented mechanism for the control of the subcellular lo-
calization of cellular proteins, by modulation of both nuclear
import (19, 21, 23) and actin binding (1, 24).
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